Myeloma-Associated Orbital Amyloidosis

被引:10
|
作者
Goshe, Jeff M. [1 ]
Schoenfield, Lynn [2 ]
Emch, Todd [3 ]
Singh, Arun D. [1 ,4 ]
机构
[1] Cole Eye Inst, Cleveland Clin, Cleveland, OH USA
[2] Cleveland Clin, Dept Pathol, Cleveland, OH USA
[3] Cleveland Clin, Dept Neurol, Cleveland, OH USA
[4] Cole Eye Inst, Div Ophthalmol, 9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
Orbital amyloidosis; Myeloma-associated amyloidisis;
D O I
10.3109/01676831003660671
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Orbital amyloidosis is extremely rare and may be localized finding or secondary to a systematic process. The majority of the patients with orbital amyloidosis have primary localized disease. We report a 55 year old male with multiple myeloma and secondary amyloidosis who presented with incidental bilateral orbital masses on MRI. Biopsy revealed amyloid deposition. We review the previously published cases of the orbital amyloidosis secondary to systematic light chain (AL) amyloidosis, including one patient with multiple myeloma. The clinical signs and symptoms, histopathologic findings, and radiographic features of orbital amyloidosis are discussed.
引用
下载
收藏
页码:274 / 277
页数:4
相关论文
共 50 条
  • [21] Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?
    Bahlis, N. J.
    Lazarus, H. M.
    BONE MARROW TRANSPLANTATION, 2006, 38 (01) : 7 - 15
  • [22] Multiple myeloma-associated amyloidosis and acral localized acquired cutis laxa
    Appiah, Yvette E.
    Onumah, Neh
    Wu, Hong
    Elenitsas, Rosalie
    James, William
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : S32 - S33
  • [23] Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?
    N J Bahlis
    H M Lazarus
    Bone Marrow Transplantation, 2006, 38 : 7 - 15
  • [24] Nail changes as the only skin abnormality in myeloma-associated systemic amyloidosis
    Mancuso, G
    Fanti, PA
    Berdondini, RM
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (03) : 471 - 472
  • [25] Nail dystrophy as the initial sign of multiple myeloma-associated systemic amyloidosis
    Xu, Jia
    Tahan, Steven
    Jan, Farhana
    Do, Daihung
    Wu, Hong
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (06) : 543 - 545
  • [26] Therapeutic Effects of Lenalidomide on Hemorrhagic Intestinal Myeloma-associated AL Amyloidosis
    Nagano, Seiji
    Mori, Minako
    Kato, Aiko
    Ono, Yuichiro
    Aoki, Kazunari
    Arima, Hiroshi
    Takiuchi, Yoko
    Tabata, Sumie
    Yanagita, Soshi
    Matsushita, Akiko
    Ishikawa, Takayuki
    Imai, Hiroyuki
    Takahashi, Takayuki
    INTERNAL MEDICINE, 2013, 52 (10) : 1101 - 1105
  • [27] Multiple myeloma-associated skin light chain amyloidosis: A case of misdiagnosis
    Xiao, Li
    Lin, Fengxia
    Xiao, Rong
    Hu, Chun
    Deng, Mingyang
    Li, Daiqiang
    She, Xiaoling
    Liu, Fuyou
    Sun, Lin
    ONCOLOGY LETTERS, 2016, 11 (06) : 3617 - 3620
  • [28] Multiple myeloma-associated light chain amyloidosis presenting as verrucous lingual masses
    Lee, KH
    Lee, JS
    Cho, YK
    Kim, SY
    Yoo, JY
    Park, CJ
    ACTA DERMATO-VENEREOLOGICA, 2005, 85 (05) : 447 - 448
  • [29] Bullous amyloidosis in a hemodialysis patient turns out to be myeloma-associated rather than hemodialysis-associated amyloidosis
    Chang, Shyue-luen
    Yang, Li-cheng
    Hong, Hong-shang
    Lai, Ping-chin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB136 - AB136
  • [30] Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor
    J. Vela-Ojeda
    M. A. García-Ruiz Esparza
    Y. Padilla-González
    E. Sánchez-Cortes
    J. García-Chávez
    L. Montiel-Cervantes
    E. Reyes-Maldonado
    A. Majluf-Cruz
    H. Mayani
    Annals of Hematology, 2009, 88 : 59 - 66